Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 209204
Company: SUN PHARMA CANADA

Products on ANDA 209204

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
IBUPROFEN	IBUPROFEN	100MG/5ML	SUSPENSION;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 209204

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
06/23/2017	ORIG-1	Approval		STANDARD		Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/21/2024	SUPPL-12	Labeling-Package Insert, Labeling-Medication Guide		Label is not available on this site.
04/30/2021	SUPPL-8	Labeling-Package Insert, Labeling-Patient Package Insert, Labeling-Medication Guide		Label is not available on this site.
07/22/2019	SUPPL-4	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 209204

IBUPROFEN

SUSPENSION;ORAL; 100MG/5ML
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
IBUPROFEN	IBUPROFEN	100MG/5ML	SUSPENSION;ORAL	Prescription	No	AB	074978	ACTAVIS MID ATLANTIC
IBUPROFEN	IBUPROFEN	100MG/5ML	SUSPENSION;ORAL	Prescription	No	AB	209178	AUROBINDO PHARMA LTD
IBUPROFEN	IBUPROFEN	100MG/5ML	SUSPENSION;ORAL	Prescription	No	AB	076925	PADAGIS US
IBUPROFEN	IBUPROFEN	100MG/5ML	SUSPENSION;ORAL	Prescription	No	AB	215311	STRIDES PHARMA
IBUPROFEN	IBUPROFEN	100MG/5ML	SUSPENSION;ORAL	Prescription	No	AB	209204	SUN PHARMA CANADA